France Veterinary Oncology Market Size & Outlook, 2022-2030
France veterinary oncology market, 2018-2030 (US$M)
Related Markets
France veterinary oncology market highlights
- The France veterinary oncology market generated a revenue of USD 12.2 million in 2022 and is expected to reach USD 31.6 million by 2030.
- The France market is expected to grow at a CAGR of 12.6% from 2023 to 2030.
- In terms of segment, chemotherapy was the largest revenue generating therapy in 2022.
- Immunotherapy is the most lucrative therapy segment registering the fastest growth during the forecast period.
Veterinary oncology market data book summary
| Market revenue in 2022 | USD 12.2 million |
| Market revenue in 2030 | USD 31.6 million |
| Growth rate | 12.6% (CAGR from 2022 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Immunotherapy |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Surgery, Radiology, Chemotherapy, Immunotherapy |
| Key market players worldwide | Zoetis Inc Class A, Karyopharm Therapeutics Inc, Varian, Accuray Inc, PetCure Oncology, Boehringer Ingelheim, Elanco Animal Health Inc, One Health Group, Regeneus |
Other key industry trends
- In terms of revenue, France accounted for 5.3% of the global veterinary oncology market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany veterinary oncology market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 2.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Oncology Market Scope
Veterinary Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France veterinary oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary oncology market will help companies and investors design strategic landscapes.
Chemotherapy was the largest segment with a revenue share of 27.87% in 2022. Horizon Databook has segmented the France veterinary oncology market based on surgery, radiology, chemotherapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing awareness among pet owners about veterinary oncology and the rising importance of early detection & treatment contribute to the market share.
Furthermore, educational campaigns by veterinary professionals & animal health organizations and knowledge sharing in cancer research & treatments in the human medical field are expected to help drive the awareness and demand for cancer treatment in pets in the near future.
Advancements in veterinary medicine, including diagnostics, treatment options, and supportive care for cancer in animals, further contribute to the growth of the veterinary oncology market.
Reasons to subscribe to France veterinary oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France veterinary oncology market databook
-
Our clientele includes a mix of veterinary oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France veterinary oncology market, including forecasts for subscribers. This country databook contains high-level insights into France veterinary oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France veterinary oncology market
France Veterinary Oncology Market Share, 2022 & 2030 (US$M)
France veterinary oncology market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
